Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity

By Diminsky D.   Schirmbeck R.   Reimann J.   Barenholz Y.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 637-647

Elsevier

Access to resources Recommend Favorite

DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice

By Davis H.L.   Millan C.L.B.   Mancini M.   McCluskie M.J.   Hadchouel M.   Comanita L.   Tiollais P.   Whalen R.G.   Michel M.-L.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 849-852

Elsevier

Access to resources Recommend Favorite

Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice

By Zheng B.-J.   Ng M.-H.   He L.-F.   Yao X.   Chan K.-W.   Yuen K.-Y.   Wen Y.-M.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4219-4225

Elsevier

Access to resources Recommend Favorite

Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw 2 , adr, ayw 3 ) in measuring the immune response after vaccination

By Heijtink R.A.   Bergen P.v.   Melber K.   Janowicz Z.A.   Osterhaus A.D.M.E.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2191-2196

Elsevier

Access to resources Recommend Favorite

Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine

By Netter H.J.   Woo W.-P.   Tindle R.   Macfarlan R.I.   Gowans E.J.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2692-2697

Elsevier

Access to resources Recommend Favorite